$MRK Just Got a New Reason to Run

$Merck(MRK)$

$Merck & Co., Inc.(MRK) Rallies +1.42% to $149.86: Pharma Giant Nears 52-Week High with Bullish MACD Momentum, $156 Target in Focus 📈💊

Latest Close Data: MRK closed at $149.86 (+1.42%) on Sep 2, 2026, just 4.5% below its 52-week high of $156.92. Volume was 9.87M shares (Volume Ratio 0.98), turnover rate 0.40%.

Core Market Drivers: HSBC upgraded MRK from Hold to Buy on Sep 1, fueling the 2.6% pre-market pop. The mRNA cancer vaccine (intismeran autogene + Keytruda) Phase III success continues to attract analyst upgrades. Morgan Stanley lifted PT from $116 to $179 with Overweight rating.

Technical Analysis: MACD remains bullish with DIF 5.91 > DEA 5.71, histogram positive at 0.38. RSI(6) at 58.7 and RSI(24) at 63.7 — momentum recovering but not overbought. KDJ shows K=50.6, D=65.9, J=20.2, suggesting short-term consolidation after pullback.

Key Price Levels:

• Primary Support: $116.72 (Sep 1 low)

• Strong Resistance: $152.18 (recent pivot high) → then $156.92 (52-week high)

• Immediate Pivot: $150.00 (round number + pre-market level)

Valuation Perspective: Forward P/E at 53.8x is far above the 24.8x historical average and +1 Std.Dev band of 45.9x. TTM P/E is 117.7x, P/S 5.55x — valuation remains stretched versus peer median.

Analyst Targets: 28 analysts with mean target of $145.77 (range $95–$186). Ratings: 7 Strong Buy, 16 Buy, 9 Hold. Morgan Stanley’s new $179 target implies +19% upside.

Weekly Outlook: Expect MRK to test $150 psychological level first. A breakout above $152.18 opens path to $156.92 (52-week high). Failure to hold $147.76 (yesterday close) could retest $140 support. Consolidation range: $144–$154.

⚠️ Risk Disclaimer: This technical analysis is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Trading involves substantial risk.

🎯$Merck & Co., Inc.(MRK) Options Strategy: Bull Call Spread (Debit Spread)

• Underlying: MRK (Merck & Co., Inc.)

• View: Moderately bullish; expecting a test of the $152.18 pivot high and a potential breakout toward the 52-week high of $156.92, supported by bullish MACD momentum and recent analyst upgrades (HSBC Buy, Morgan Stanley OW with $179 PT).

• Strategy Type: Debit Spread / Defined Risk Bullish

• Option Contract Portfolio:

  • Buy to Open: MRK 2026-09-18 145 Call @ $5.90 (mid)

  • Sell to Open: MRK 2026-09-18 155 Call @ $0.86 (mid)

  • Note: The 145 call has high open interest (779) and is one strike below current price ($149.86), offering a good balance of intrinsic + extrinsic value. The 155 call sits just above the recent pivot high ($152.18) and below the 52-week high ($156.92), acting as a realistic short-term cap.

• Max Gain & Loss:

  • Max Gain: (Width of spread − Net Debit) = ($10.00 − $5.04) × 100 = $496 per spread

  • Max Loss: Net Debit paid = $504 per spread

• Initial Cost/Credit: Net Debit of $5.04 (or $504 per contract)

Investing is a long journey. Knowing when to move matters — and so does knowing when to recharge.

Markets may not slow down, but you can. Whether it’s a quick break between trading sessions or a long journey, staying comfortable helps you reset for what comes next. The new Night Trading Memory Foam Pillow features 360° ergonomic support and slow-rebound memory foam that gently conforms to your neck, plus a roll-up design that makes it easy to bring wherever you go.

https://laohu8.com/J/redeemGift?goodID=100540&type=delivery

Redeem the new Night Trading Memory Foam Pillow in Tiger Coins Mall, and stay supported for the journey ahead.